While Insightec has raked in hundreds of millions of dollars in VC funding in recent years based largely on the strength of its Exablate Neuro platform, the company continues to expand its focused ultrasound technology beyond the brain.

Most recently, it landed 510(k) clearance from the FDA for Exablate Prostate, which uses Insightec’s signature targeted sound wave tech to destroy cancerous prostate tissue in low- or intermediate-risk patients.

Read more here.